# FDA Inspection 1286526 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - September 05, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/669253d4-be4d-43db-a8ca-3debe6b81bf4
Source feed: FDA_Inspections

> FDA Inspection 1286526 for Livzon Group (Ningxia) Pharmaceutical Co., Ltd. on September 05, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286526
- Company Name: Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
- Inspection Date: 2025-09-05
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1286526 - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/17259637-8bb1-4159-a363-354a53004e96)
- [FDA Inspection 1286526 - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/3807d04f-359d-4381-adeb-4bb36afcc7bc)
- [FDA Inspection 1286526 - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/851f62b2-0417-46fb-a423-77ac6fae1dd7)
- [FDA Inspection 1115730 - 2019-12-06](https://www.globalkeysolutions.net/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/a0f62698-dff7-47a7-8640-a8960fab5408)
- [FDA Inspection 1070291 - 2018-10-19](https://www.globalkeysolutions.net/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/a82b46fe-c65c-416b-a72d-567fb166f2f3)

Company: https://www.globalkeysolutions.net/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8